This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
Target Wants Bank Claims Thrown Out a Year After Data Breach

Five banks are suing Target Corporation (TGT) for costs incurred stemming from the retailer's epic data breach last year, involving 40 million credit card accounts.

CBS and Dish Agree to Short Deadline Extension, Avoiding Blackout

CBS and Dish Network have come to a short-term agreement, preventing a potential blackout for millions of satellite TV subscribers.

Cramer: My Dad Taught Me Work Ethic, Good Values as a Businessman

After the loss of his father, Jim Cramer details the lessons he learned from his dad about being a good and honorable businessman.

Why Ex-Obama Chief of Staff Daley Joined JPM Trading Star Gulati

Hedge fund Argentiere Capital focuses on volatility.

Sotheby's & Hertz Rally on CEO Changes, Dow Up Triple Digits

Stocks are off its highs after a strong start but are still at record levels.

Real Money Previews

Jim Cramer on His Dad: ‘Our Last Day Together Was Our Best One’

A tribute to Ken Cramer, or 'Pop', father of founder, 'Jimmy'.

Jim Cramer on the Stock Market: Thoughts on Foolish Groupthink

The latest example: Reams of wrongheaded hedge-fund short plays off the Ebola crisis.

Watch Out! These 'Torpedo' Stocks Could Sink Your Portfolio

It's worth paying attention to these potential portfolio killers.

Mad Money Recap

Jim Cramer's 'Mad Money' Recap: Learn From My Life Lessons

Cramer tells how he came to make the markets his life and where he got his most valuable lessons about money and investing.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

Time to Sell These 5 'Toxic' Stocks: Bitauto Holdings and More

For investors looking to buy one of these positions, it makes sense to wait for more favorable technical conditions (and a lower share price) before piling in.

5 Earnings Short-Squeeze Plays: Workday, Trina Solar and More

You only need to find a few short-squeeze plays to juice your annual returns.

Must-See Charts: How to Trade IBM, Applied Materials and More

Skilled technical traders can bank gains as much as 90% of the time.

5 Stocks With Big Insider Trading: Groupon, Jive Software and More

Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

5 Hated Short-Squeeze Stocks Ready to Pop: Burger King and More

Shorting in U.S. stocks is the highest it's been since September 2008. Investors hate stocks right now.


Don't Just Sit There And Let Your Health Insurance Automatically Renew for 2015

There are a lot of changes coming to the healthcare exchanges for 2015...and you'll want to take advantage of that.

How to Avoid War Between Homeowner Associations and Residents

Community Association Institute says 63 Million Americans live in communities under Home Owner Association jurisdiction. That means ripe territory for conflict is abundant.

Corinthian Colleges Sells 56 of it 108 Campuses to Student Loan Guaranty Agency ECMC

The fate of 52 remaining campuses is unknown while student defections and lay-offs are waiting in the wings.

You May Be Getting a Big Break on your Student Loan Debt

Private student loan payments may be lowered by nearly a third – or forgiven completely.

Consumer Credit Scores Are On the Rise, Along With Bank Card Use

This has been a notable year for borrowing, with more credit being extended and taken. Next year looks good too.


Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma

The $3.3 billion paid by Royalty Pharma to the Cystic Fibrosis Foundation to acquire royalty rights to Vertex Pharmaceuticals' cystic fibrosis drugs suggests investors are under-estimating peak sales.

Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher'

TheStreet's Jim Cramer says Agios Pharmaceuticals' positive Phase 1 data for its leukemia treatment is impressive. As a result, shares are going higher despite doubling since July.

Beyond Wall St.

Deal News

Australian Manufacturing Company Orica Sells Its Chemical Business to Blackstone Group

After marketing its chemical business for more than a year, Australian manufacturing company Orica Ltd. is selling the unit to funds advised by Blackstone Group LP.

Facebook's $2 Billion Oculus Play Still a Virtual Reality

Though Sony and Google have followed suit, a dearth of VR content limits the technology's commercial use.

Jana Partners Unveils Potential Board Slate for PetSmart

The activist hedge fund, with a 9.8% stake, is pressing the pet supplies chain to put itself up for sale.

Spin Space

Jim Cramer

Dicker/Cramer: 'Oil's Endless Bid' Takes a Long Holiday

Dan Dicker, Energy contributor to TheStreet, talks to Jim Cramer about how under-appreciated financial inputs have impacted oil's fast drop in price.

Herb Greenberg

Greenberg: How Hertz Fooled So Many Hedge Fund Managers

But suing Audit Integrity wasn't such a good idea.

Stephanie Link

Dicker/Link: Tubular Bells Offshore Project Begins Production - but No Reason Yet to Invest

Dan Dicker talks with Stephanie Link, co-portfolio director of Action Alerts, about the beginnings of production of a $2.3 billion offshore project co-owned by Hess and Chevron.

Chris Ciaccia

Intel's Mobile Future Seems On Track After Analyst Day: What Wall Street's Saying

Intel shares tacked on gains following a sharp run up after the company held its analyst day, announcing 2015 guidance, soothing investors' about the future of the world's largest ...

Adam Feuerstein

Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Dan Freed

Ben Bernanke, ex-U.K. Central Bank Chief Bearish on Europe, Bitcoin

Bernanke and Mervyn King thought the global economy would recover more quickly and are reportedly pessimistic about a European revival.

Ted Reed

Delta Order Affirms the Age of the Airbus A350 Is Approaching

The Airbus A350 had a good week as Delta announced an order and Qatar announced the timing for the first delivery.

Leon Lazaroff

Aereo May Be Dead, But Over-The-Top Television Is Just Beginning

Aereo's bankruptcy brings to an end a company that filled the public's demand for choice and mobility. Another provider would be wise to acquire its technology.

Submit an article to us!
DOW 17,787.04 +68.04 0.38%
S&P 500 2,058.27 +5.52 0.27%
NASDAQ 4,706.9320 +5.0650 0.11%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs